In this work, the two types of nanostructured surfaces were evaluated with respect to the immunochemical detection of CA125 and HE4, two ovarian cancer markers, aiming at the development of a system that could determine both analytes simultaneously in human serum samples. This evidence concerns the gene WFDC2 and ovarian cancer.